Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan

Direct oral anticoagulants (DOACs) were developed to compensate for the demerits of warfarin. In Japan, three factor Xa inhibitors are used for the treatment of venous thromboembolism (VTE): edoxaban, rivaroxaban, and apixaban. Despite problems, such as the inability to monitor their effect and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Mashio, Yamada, Norikazu, Ito, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453680/
https://www.ncbi.nlm.nih.gov/pubmed/28392512
http://dx.doi.org/10.5551/jat.RV17005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453680/
https://www.ncbi.nlm.nih.gov/pubmed/28392512
http://dx.doi.org/10.5551/jat.RV17005

Ejemplares similares